Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.
about
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathyMacular function evaluated by focal macular electroretinograms after reduced fluence photodynamic therapy in eyes with polypoidal choroidal vasculopathy.Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot studyCombined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up.The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy.Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome.Ocular manipulation reduces both ipsilateral and contralateral electroretinograms.The chorioretinal damage caused by different half parameters of photodynamic therapy in rabbits.One-year results of photodynamic therapy combined with intravitreal ranibizumab for exudative age-related macular degeneration.1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathyCombined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathyChoroidal neovascularisation in pathological myopia: an update in managementMultiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.A Review of Subthreshold Micropulse Laser for Treatment of Macular DisordersLong-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration.Treatment of polypoidal choroidal vasculopathy by photodynamic therapy, aflibercept and dexamethasone triple therapy.Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy.Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy.Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy.Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy.Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.Focal macular electroretinograms after photodynamic therapy combined with intravitreal bevacizumab.
P2860
Q26824756-88D63613-B6A2-4736-840C-4E43D285BC1FQ31044313-CF4BAAC1-43F8-4B61-A6F7-88218504E2E5Q33239033-E6F91FA7-67D9-43B3-849D-DED567990B24Q34245287-58B38B57-89D4-44CA-A08C-AC04287E7C05Q34394791-52FCD7E9-09E1-4D59-AAB4-B87CDC56D822Q34718477-5C5AC5BD-4DF4-4112-AA9D-64CFEE11B945Q34754704-04174DB9-AD9D-4569-AA2A-E76C5F02E60BQ35192101-D573D576-1504-4E3E-B171-F0CD0EC414D3Q35607461-EB8BD1B8-C0A0-4379-917B-7C521DCADA9AQ35677770-B76DBF1A-65D9-4B09-9B5E-8A61CF2D18E5Q35761642-CED888D3-29BB-424C-AE48-CC962221A051Q35762763-ABA227FE-48B0-479A-BDA5-E2CD98610320Q35782233-081A6DD9-3D46-4468-90A7-B39A1CC488F9Q36071607-D24A24E1-78CF-4BD9-A230-A42CA313735FQ36290241-EAC00F9C-C89C-4C5A-A780-7AE379EFBFB9Q36326807-C2AF88D5-E239-4CFE-9EB3-F0011F33A671Q36379671-81923000-41A5-4B6F-8DBE-80396071D7A6Q36407625-C1E7DF89-BE0D-421C-ADFD-BE392239FF7FQ36977430-C7761F4D-2860-4BD5-A2A3-4303940496DBQ37416874-649E9DA1-E493-4CFF-8591-A6C050BF2233Q41190093-A4FE7409-E0B5-42B9-A5F6-0BBE72E1A32EQ41362947-8BB5EE4B-4402-429B-9AC5-D41FAC5E01C9Q41484477-158550C0-9995-412E-ABFA-E10155DA9109Q41746219-6CCF9E3E-480B-4552-A471-557ADF086583Q50484261-82DBFBE9-C5DC-473C-AFCB-D2A1DE92196FQ50536623-68CD93B5-025D-49DF-BC8D-5ED39308DC5A
P2860
Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Transient reduction in retinal ...... am after photodynamic therapy.
@en
Transient reduction in retinal ...... am after photodynamic therapy.
@nl
type
label
Transient reduction in retinal ...... am after photodynamic therapy.
@en
Transient reduction in retinal ...... am after photodynamic therapy.
@nl
prefLabel
Transient reduction in retinal ...... am after photodynamic therapy.
@en
Transient reduction in retinal ...... am after photodynamic therapy.
@nl
P1476
Transient reduction in retinal ...... am after photodynamic therapy.
@en
P2093
Timothy Y Y Lai
Wai-Man Chan
P304
P356
10.1016/J.AJO.2003.11.079
P407
P577
2004-05-01T00:00:00Z